Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

[Current service invention patents and growth pathways on basis of cluster analysis].

Yang XJ, Xiao SY.

Zhongguo Zhong Yao Za Zhi. 2012 Sep;37(17):2656-60. Chinese.

PMID:
23236772
2.

[Regional development of patents of traditional Chinese medicine compounds on basis of cluster analysis].

Yang X, Xiao S.

Zhongguo Zhong Yao Za Zhi. 2012 Aug;37(16):2472-7. Chinese.

PMID:
23234153
3.

[Cluster analysis on authorized patents of compound traditional Chinese medicines with different efficacy in 2010].

Yang X, Xiao S, Guo Z.

Zhongguo Zhong Yao Za Zhi. 2012 Aug;37(16):2478-82. Chinese.

PMID:
23234154
4.

[Analyses on positive influence of harmonous development of traditional Chinese medicine compounds' researchs and patent protection].

Yang X, Xiao S, Guo Z, Wang Z, You Y.

Zhongguo Zhong Yao Za Zhi. 2012 Jan;37(1):9-12. Chinese.

PMID:
22741453
5.
6.

[Analysis on patent network of compound Danshen extracts built by Tasly].

Liu W, Zou WJ, Wang PL, Xu X, Lei HM.

Zhongguo Zhong Yao Za Zhi. 2013 Jan;38(1):133-5. Chinese.

PMID:
23596890
7.

The patent bargain.

[No authors listed]

Nature. 2013 Dec 12;504(7479):187-8. No abstract available.

PMID:
24350371
8.
9.

[Global patent overview of Ginkgo biloba preparation].

Cheng XM, Lei HM, Liu W.

Zhongguo Zhong Yao Za Zhi. 2013 Sep;38(17):2889-93. Chinese.

PMID:
24380318
10.

Must an inventor "possess" an invention to patent it?

Woessner WD, Chadwick RA.

Cold Spring Harb Perspect Med. 2014 Sep 18;4(11):a020867. doi: 10.1101/cshperspect.a020867. Review.

11.

Basics of US patents and the patent system.

Elliott G.

AAPS J. 2007 Aug 24;9(3):E317-24. Review.

12.

[Current quality research situation of precious Chinese patent medicine].

Lin L, Liu XQ, Xu H.

Zhongguo Zhong Yao Za Zhi. 2008 Feb;33(3):329-33. Chinese.

PMID:
18536475
14.

A patent problem.

[No authors listed]

Nature. 2015 May 21;521(7552):159-60. doi: 10.1038/521259b. No abstract available.

PMID:
25993919
16.
17.

Patents: a tool to bring innovation from the lab bench to the marketplace.

Li ZY, Meyer W.

Methods Mol Biol. 2014;1152:297-310. doi: 10.1007/978-1-4939-0563-8_18.

PMID:
24744041
18.

Patent-to-patent versus patent family-to-patent family citations and the impact of an invention.

Walter D.

Pharm Pat Anal. 2014 May;3(3):219-21. doi: 10.4155/ppa.14.20. No abstract available.

19.

Enabling policy planning and innovation management through patent information and co-authorship network analyses: a study of tuberculosis in Brazil.

Vasconcellos AG, Morel CM.

PLoS One. 2012;7(10):e45569. doi: 10.1371/journal.pone.0045569. Epub 2012 Oct 3.

20.

Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents.

Seoane-Vazquez E, Rodriguez-Monguio R, Szeinbach SL, Beyer A, Visaria J.

Food Drug Law J. 2009;64(1):171-81.

PMID:
19998745

Supplemental Content

Support Center